Peptide vaccination therapy: Towards the next generation

MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation

(2016) Kazuyo Yasuda et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy

(2016) R. Morita et al.   CLINICAL CANCER RESEARCH

Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy

(2016) M. V. Maus et al.   CLINICAL CANCER RESEARCH

The future of immunotherapy for sarcoma

(2016) Tomohide Tsukahara et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Prospects for gene-engineered T cell immunotherapy for solid cancers

(2016) Christopher A Klebanoff et al.   NATURE MEDICINE

Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance

(2016) Kenji Murata et al.   OncoImmunology

Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma

(2015) N. Yamazaki et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy

(2015) K. Pilipow et al.   CANCER RESEARCH

Immune responses to human cancer stem-like cells/cancer-initiating cells

(2015) Yoshihiko Hirohashi et al.   CANCER SCIENCE

New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors

(2015) C Ciccarese et al.   Expert Opinion on Drug Metabolism & Toxicology

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

(2015) N. A. Rizvi et al.   SCIENCE

Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer

(2015) Edward B. Garon   SEMINARS IN ONCOLOGY

Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma

(2014) Jean S. Lee et al.   CANCER

Finding suitable targets is the major obstacle to cancer gene therapy

(2014) Steven A Rosenberg   CANCER GENE THERAPY

Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells

(2014) Rena Morita et al.   CANCER SCIENCE

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

(2014) P. F. Robbins et al.   CLINICAL CANCER RESEARCH

Specific Targeting of a Naturally Presented Osteosarcoma Antigen, Papillomavirus Binding Factor Peptide, Using an Artificial Monoclonal Antibody

(2014) Tomohide Tsukahara et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity

(2014) Kazuyo Yasuda et al.   LABORATORY INVESTIGATION

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

(2014) Alexandra Snyder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

(2014) E. Tran et al.   SCIENCE

Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal

(2013) Yoshitaka Michifuri et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor

(2013) Sachiyo Nishida et al.   CANCER SCIENCE

Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?

(2013) Robert O Dillman et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

(2013) Richard A. Morgan et al.   JOURNAL OF IMMUNOTHERAPY

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

(2013) Paul F Robbins et al.   NATURE MEDICINE

Ectopically Expressed Variant Form of Sperm Mitochondria-Associated Cysteine-Rich Protein Augments Tumorigenicity of the Stem Cell Population of Lung Adenocarcinoma Cells

(2013) Akari Takahashi et al.   PLoS One

High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma

(2013) Makoto Emori et al.   PLoS One

Identification of Novel Human Leukocyte Antigen-A*0201-Restricted, Cytotoxic T Lymphocyte Epitopes on CD133 for Cancer Stem Cell Immunotherapy

(2013) Jianfei Ji et al.   Stem Cells Translational Medicine

HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem-like Cells

(2012) S. Nishizawa et al.   CANCER RESEARCH

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group

(2012) Satoshi Kawaguchi et al.   CANCER SCIENCE

Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients

(2012) Hidekazu Kameshima et al.   CANCER SCIENCE

Gene Expression Profiles of Prostate Cancer Stem Cells Isolated by Aldehyde Dehydrogenase Activity Assay

(2012) Sachiyo Nishida et al.   JOURNAL OF UROLOGY

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents

(2012) Patrick A. Thompson et al.   Current Oncology Reports

Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients

(2011) Hidekazu Kameshima et al.   CANCER SCIENCE

Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma

(2011) Masanobu Kano et al.   CANCER SCIENCE

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

(2011) Paul F. Robbins et al.   JOURNAL OF CLINICAL ONCOLOGY

SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity

(2011) Munehide Nakatsugawa et al.   LABORATORY INVESTIGATION

A human memory T cell subset with stem cell–like properties

(2011) Luca Gattinoni et al.   NATURE MEDICINE

Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer

(2010) Akihiro Miyazaki et al.   CANCER SCIENCE

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

(2010) Richard A Morgan et al.   MOLECULAR THERAPY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas

(2009) M Murase et al.   BRITISH JOURNAL OF CANCER

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer

(2009) Ichiya Honma et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor

(2009) Tomohide Tsukahara et al.   Journal of Translational Medicine

Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma

(2008) Tomohide Tsukahara et al.   CANCER SCIENCE